Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Thiocyanic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiocyanic Acid SCHEMBL4777559 | 1.00 | — | — | |
| Thiocyanic Acid SCHEMBL31168667 | 1.00 | — | — | |
| Thiocyanic Acid SCHEMBL17160900 | 1.00 | CA1 (0.40) | — | |
| Thiocyanic Acid SCHEMBL1325551 | 1.00 | CA1 (0.40) | — | |
| Thiocyanic Acid SCHEMBL9005785 | 1.00 | — | — | |
| Thiocyanic Acid SCHEMBL36260 | 1.00 | — | — | |
| Thiocyanic Acid SCHEMBL28859076 | 1.00 | CA1 (0.40) | — | |
| Thiocyanic Acid SCHEMBL9447624 | 0.94 | — | — | |
| Thiocyanic Acid SCHEMBL2174132 | 0.94 | — | — | |
| Thiocyanic Acid SCHEMBL2174127 | 0.94 | CA1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119870-A | Ultraphobic heat-conducting insulating coating and preparation method thereof | 广州德海高分子材料科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-111971056-B | Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration | 普罗维瓦制药公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119072301-A | Matrix-bound nanovesicles encapsulated in hydrogels | 联邦高等教育系统匹兹堡大学 | 2024-12-03 | — | — | CN | disclosed |
| CN-118806792-A | Substrate-bound nanovesicles and uses thereof | 高等教育联邦系统-匹兹堡大学 | 2024-10-22 | — | — | CN | disclosed |
| CN-109152737-B | Substrate-bound nanovesicles and uses thereof | 高等教育联邦系统-匹兹堡大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-110582286-B | Ocular application of matrix-bound vesicles (MBVs) | 联邦高等教育系统匹兹堡大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-115515607-A | Matrix-binding vesicles (MBV) for use in the treatment of acute respiratory distress syndrome | 联邦高等教育系统匹兹堡大学 | 2022-12-23 | — | — | CN | disclosed |
| CN-114615987-A | Use of MBV for the treatment of autoimmune diseases | 联邦高等教育系统匹兹堡大学 | 2022-06-10 | — | — | CN | disclosed |
| CN-111971056-A | Probiotic formulations for the treatment and alleviation of metabolic and oxidative stress, inflammation and neurodegeneration | 普罗维瓦制药公司 | 2020-11-20 | — | — | CN | disclosed |